Comparing Radiotherapy Techniques for Hodgkin's Lymphoma
Author Information
Author(s): Koh Eng-Siew, Tran Tu Huan, Heydarian Mostafa, Sachs Rainer K, Tsang Richard W, Brenner David J, Pintilie Melania, Xu Tony, Chung June, Paul Narinder, Hodgson David C
Primary Institution: University of Toronto, Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
Hypothesis
Does involved-field radiotherapy (IFRT) reduce the risk of second cancers compared to mantle radiotherapy (RT)?
Conclusion
The study found that modern IFRT significantly reduces the risk of radiation-induced second cancers compared to traditional mantle RT.
Supporting Evidence
- Moving from 35 Gy mantle RT to 35 Gy IFRT reduces predicted excess relative risks for female breast and lung cancer by approximately 65%.
- The median reduction in integral dose to the whole heart with the transition to 35 Gy IFRT was 35%.
- There was no significant reduction in thyroid dose.
Takeaway
This study shows that using a smaller area for radiation treatment can help protect healthy parts of the body and lower the chances of getting another cancer later.
Methodology
The study analyzed dose-volume histograms for patients receiving different radiotherapy protocols and estimated second cancer risks using a dosimetric risk-modeling approach.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the limited sample size for ERR estimates.
Limitations
The study's biological model has inherent limitations and relies on several assumptions; also, there was inter-physician variability in treatment planning.
Participant Demographics
{"gender":{"females":25,"males":16},"median_age":27,"smokers":14}
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website